Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia. (30th March 2016)

• Record Type: Journal Article
• Authors: Sannier, Aurélie; Cazejust, Julien; Lequoy, Marie; Cervera, Pascale; Scatton, Olivier; Rosmorduc, Olivier; Wendum, Dominique
• Is Part Of: Liver international. Volume 36:Number 11(2016)
• Page Start: 1668
• Page End: 1676
• Publication Date: 2016-03-30
• Subjects: focal nodular hyperplasia -- hepatocellular adenoma -- liver biopsy -- magnetic resonance imaging; Liver -- Periodicals; Liver -- Diseases -- Periodicals; 616.362
• DOI: 10.1111/liv.13113
• Languages: English
• ISSNs: 1478-3223

Abstract

Abstract: Background & Aims: The contribution of liver biopsy for the diagnosis of presumed benign hepatocellular lesions lacking the diagnostic features of focal nodular hyperplasia (FNH) on magnetic resonance imaging (MRI) is unknown. We evaluated liver biopsy and MRI performances in this setting. Methods: Magnetic resonance imaging and slides of liver biopsies performed for a presumed benign hepatocellular lesion (2006–2013) without the typical features of FNH on MRI were blindly reviewed ( n = 45). Eighteen lesions were surgically removed and also analyzed. The final diagnosis was the diagnosis established after surgery or on the biopsy in the absence of surgery. Results: The final diagnosis was FNH ( n = 19), hepatocellular adenoma (HCA, n = 15), hepatocellular carcinoma ( n = 3) and indefinite ( n = 4). Four lesions corresponded to non hepatocellular lesions. FNH, HNF1A mutated and inflammatory HCA were diagnosed accurately on the biopsy in 95%, 67% and 100% of the cases respectively. Diagnostic performance of liver biopsy for HNF1A mutated HCA was lower because of the lack of non‐tumoral tissue. Diagnosis based on morphological analysis was certain and correct in 27 cases. Immunostaining allowed a definite diagnosis in 12 additionnal cases. Radiological diagnosis was in agreement with the histological diagnosis in 75.6% of the cases, with a very high sensitivity (97%) and specificity (100%) for the diagnosis of HNF1A mutated HCA. Conclusions: Liver biopsy has a good diagnostic performance particularly for FNH and inflammatory HCA, and sampling of non‐lesional tissue is highly recommended. A biopsy does not seem necessary if H‐HCA is diagnosed on MRI.